CD19/22 CAR-T cells

chimeric antigen receptor T cells targeting CD19 and CD22

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19/22 CAR-T cells, covering 2021-08-02 to 2021-08-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell Lymphoma [Phase 2]